Trung tâm Thông tin - Thư viện Trường Đại học Y Dược Hải Phòng

NLM	C5
Tác giả CN	Hoàng Đình Khánh
Nhan đề	Potential Protective Effect of Hepatitis B Immunity Against Diabetes Mellitus: A Retrospective Propensity-Matched Cohort Study
Thông tin xuất bản	MDPI,2025
Tóm tắt	The HBV-immunized group had a 15% lower diabetes risk than the HBV-unimmunized group (HR: 0.85 [0.84–0.87]). A dose–response effect was observed, with higher HBsAb levels showing a greater reduction in the risk of diabetes. HBsAb levels of ≥100 and ≥1000 mIU/mL were associated with 19% (HR: 0.81 [0.80–0.83]) and 43% (HR: 0.57 [0.54–0.60]) reductions in diabetes risk, respectively, compared with HBsAb < 10 mIU/mL. The reduced risk of diabetes was associated with age. Immunized individuals aged 18 to 44 years, 45 to 64 years, and ≥65 years had 20% (HR: 0.80 [0.78–0.82]), 11% (HR: 0.89 [0.87–0.92]), and 12% (HR: 0.88 [0.84–0.91]) lower diabetes risks, respectively, compared with unimmunized individuals.
Thuật ngữ chủ đề	Internal medicine
Từ khóa tự do	Hepatitis B; Diabetes
Địa chỉ	100Kho Bài báo quốc tế(1): BQT00084
Tệp tin điện tử	https://doi.org/10.3390/diagnostics15131610
Tệp tin điện tử	https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg

MARC

Hiển thị đầy đủ trường & trường con

Tag	Giá trị
000	00000nab#a2200000ui#4500
001	34007
002	13
004	C27C7FA2-4D88-4DB3-B088-72423B9D3568
005	202605181524
008	081223s2025 vm\| vie
009	1 0
039	[ ] \|y 20260518152452 \|z phuongntt
041	[ ] \|a Eng
084	[ ] \|a C5
100	[ ] \|a Hoàng Đình Khánh
245	[ ] \|a Potential Protective Effect of Hepatitis B Immunity Against Diabetes Mellitus: A Retrospective Propensity-Matched Cohort Study
260	[ ] \|b MDPI, \|c 2025
520	[ ] \|a The HBV-immunized group had a 15% lower diabetes risk than the HBV-unimmunized group (HR: 0.85 [0.84–0.87]). A dose–response effect was observed, with higher HBsAb levels showing a greater reduction in the risk of diabetes. HBsAb levels of ≥100 and ≥1000 mIU/mL were associated with 19% (HR: 0.81 [0.80–0.83]) and 43% (HR: 0.57 [0.54–0.60]) reductions in diabetes risk, respectively, compared with HBsAb < 10 mIU/mL. The reduced risk of diabetes was associated with age. Immunized individuals aged 18 to 44 years, 45 to 64 years, and ≥65 years had 20% (HR: 0.80 [0.78–0.82]), 11% (HR: 0.89 [0.87–0.92]), and 12% (HR: 0.88 [0.84–0.91]) lower diabetes risks, respectively, compared with unimmunized individuals.
650	[ ] \|a Internal medicine
653	[ ] \|a Hepatitis B
653	[ ] \|a Diabetes
691	[ ] \|a CTĐT Thạc sĩ Nội khoa
691	[ ] \|a CTĐT Tiến sĩ Nội khoa
773	[ ] \|t Diagnostics
852	[ ] \|a 100 \|b Kho Bài báo quốc tế \|j (1): BQT00084
856	[ ] \|u https://doi.org/10.3390/diagnostics15131610
856	[1 ] \|u https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg
890	[ ] \|a 1 \|b 0 \|c 0 \|d 0

Dòng	Mã vạch	Bản sao	Nơi lưu	Tình trạng	Cho phép yêu cầu
1	BQT00084	1	Kho Bài báo quốc tế
#1 BQT00084 Nơi lưu Kho Bài báo quốc tế Tình trạng

Bình luận